2024 MIPS eCQMs 

All measures will be calculated.  Must submit at least 6, with at least one outcome measure.

Collection Type

 

Guideline Name

MIPS eCQM CMS124

 

Quality ID: 309

Cervical Cancer Screening
 

MIPS eCQM CMS068

 

Quality ID: 130

Documentation of Current Medications in the Medical Record
 High Priority Measure: Process

MIPS eCQM
 CMS002

 

Quality ID: 134

Preventive Care and Screening: Screening for Depression and Follow-Up Plan

MIPS eCQM CMS157

 

Quality ID: 143

Oncology: Medical and Radiation - Pain Intensity Quantified

MIPS eCQM CMS129

 

Quality ID: 102

Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

MIPS eCQM
 CMS 645

 

Quality ID: 462

Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy

MIPS eCQM CMS138

 

Quality ID: 226

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

MIPS eCQM CMS139

 

Quality ID: 318

Falls: Screening for Future Fall Risk

MIPS eCQM CMS165

 

Quality ID: 236

Controlling High Blood Pressure

 

2024 Advancing Cancer Care MVP 

MVP ID: M0001 Explore Merit-based Incentive Payment System (MIPS) Value Pathways (MVPs) - QPP 

Must submit 4, with at least 1 outcome measure.

Collection Type

 

Guideline Name

MIPS CQM

 

Quality ID: 047

Advance Care Plan

MIPS eCQM
 CMS002

 

Quality ID: 134

Preventive Care and Screening: Screening for Depression and Follow-Up Plan

MIPS eCQM CMS157

 

Quality ID: 143

Oncology: Medical and Radiation - Pain Intensity Quantified

MIPS CQM

 

Quality ID: 144

Oncology: Medical and Radiation - Plan of Care for Pain

MIPS CQM

 

Quality ID: 450

Appropriate Treatment for Patients with Stage I (T1c) - III HER2 Positive Breast Cancer

MIPS CQM

 

Quality ID: 451

RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy

MIPS CQM

 

Quality ID: 452

Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies

MIPS CQM

 

Quality ID: 453

Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)

MIPS CQM

 

Quality ID: 457

Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score - better)

MIPS eCQM
 CMS 645

 

Quality ID: 462

Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy

MIPS CQM

 

Quality ID: 487

Screening for Social Drivers of Health

MIPS CQM

 

Quality ID: 490

Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors